DI COLA, ILENIA
 Distribuzione geografica
Continente #
NA - Nord America 367
EU - Europa 253
AS - Asia 55
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 677
Nazione #
US - Stati Uniti d'America 366
IE - Irlanda 176
IT - Italia 33
SG - Singapore 31
CN - Cina 18
DE - Germania 16
CZ - Repubblica Ceca 9
FI - Finlandia 7
GR - Grecia 2
HK - Hong Kong 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
IL - Israele 1
IN - India 1
LU - Lussemburgo 1
NL - Olanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
UA - Ucraina 1
Totale 677
Città #
Dublin 173
Chandler 104
Boardman 56
New York 42
Singapore 21
Ashburn 12
Lawrence 11
Princeton 11
Los Angeles 10
Brno 9
Dallas 9
Jacksonville 9
Kitzingen 8
L’Aquila 8
Lappeenranta 5
Munich 5
Shanghai 5
Cedar Knolls 4
Pescara 3
Atlanta 2
Berlin 2
Cassano d'Adda 2
Des Moines 2
Helsinki 2
Hong Kong 2
Houston 2
L'aquila 2
Novara 2
Wilmington 2
Ann Arbor 1
Athens 1
Boston 1
Bremen 1
Brussels 1
Charlotte 1
Cormeilles-en-Parisis 1
Hod HaSharon 1
Lanciano 1
Manila 1
Milan 1
Norwalk 1
Panama City 1
Piraeus 1
Pune 1
San Mateo 1
Santa Clara 1
Santiago 1
Seattle 1
Vienna 1
Washington 1
Zurich 1
Totale 547
Nome #
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 52
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 50
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 41
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 40
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 37
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 31
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 30
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 29
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 29
The pathogenic role of interferons in the hyperinflammatory response on adult-onset still’s disease and macrophage activation syndrome: Paving the way towards new therapeutic targets 28
Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature 27
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 25
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 22
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease 22
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 20
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 19
Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease 18
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 17
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 17
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 16
Adult-onset Still's disease with elderly onset: results from a multicentre study 16
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 14
Correction to: Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study (Clinical Rheumatology, (2022), 41, 3, (641-647), 10.1007/s10067-021-05929-8) 11
Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum 10
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 10
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 10
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 9
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 9
POS0237 ADULT-ONSET STILL’S DISEASE AND COVID 19 SHARE GENETIC EXPRESSION RELATED TO HYPERINFLAMMATION: DEFINING THE POSSIBLE ROLE OF THE SPECIALIZED PRO-RESOLVING LIPID MEDIATOR PROTECTIN D1 IN MODULATING MACROPHAGES POLARIZATION AND FUNCTION 7
Whole body insulin sensitivity is increased in systemic sclerosis 7
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 7
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 6
The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry 6
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 6
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 5
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 5
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 5
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 4
Totale 717
Categoria #
all - tutte 5.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 5 0 1 1 4 2 0 3 2 4 0
2021/202242 0 0 0 1 0 1 6 2 6 3 0 23
2022/2023366 14 24 5 33 15 28 11 21 194 0 14 7
2023/2024186 10 6 8 18 14 52 6 6 8 10 12 36
2024/2025101 38 14 49 0 0 0 0 0 0 0 0 0
Totale 717